Nycomed and its licence holder Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), today announced the U.S. launch of an own generic version of PR
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
Wyeth (WYE) is unexpectedly facing generic competition for its top drugs, most notably its blockbuster heartburn treatment Protonix. Generic Protonix is expected to contribute to flat sales and a pos
read more » Discuss Add this link to...Bury Add to:
| Bookmarks